GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (TSE:3349) » Definitions » Owner Earnings per Share (TTM)

COSMOS Pharmaceutical (TSE:3349) Owner Earnings per Share (TTM) : 0.00 (As of Feb. 2024)


View and export this data going back to 2004. Start your Free Trial

What is COSMOS Pharmaceutical Owner Earnings per Share (TTM)?

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

COSMOS Pharmaceutical does not have enough data to calculate Owner Earnings per Share (TTM), so as Price-to-Owner-Earnings ratio.


The historical rank and industry rank for COSMOS Pharmaceutical's Owner Earnings per Share (TTM) or its related term are showing as below:


During the past 13 years, the highest Price-to-Owner-Earnings ratio of COSMOS Pharmaceutical was 475.62. The lowest was 32.75. And the median was 45.19.


TSE:3349's Price-to-Owner-Earnings is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 20.705
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

COSMOS Pharmaceutical's Earnings per Share (Diluted) for the three months ended in Feb. 2024 was 円145.60. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was 円627.87. It's PE Ratio ratio for today is 21.88.

COSMOS Pharmaceutical's EPS without NRI for the three months ended in Feb. 2024 was 円142.90. Its EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2024 was 円630.79. It's PE Ratio without NRI ratio for today is 21.78.


COSMOS Pharmaceutical Owner Earnings per Share (TTM) Historical Data

The historical data trend for COSMOS Pharmaceutical's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical Owner Earnings per Share (TTM) Chart

COSMOS Pharmaceutical Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

COSMOS Pharmaceutical Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of COSMOS Pharmaceutical's Owner Earnings per Share (TTM)

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


COSMOS Pharmaceutical's Price-to-Owner-Earnings Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's Price-to-Owner-Earnings falls into.



COSMOS Pharmaceutical Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

COSMOS Pharmaceutical does not have enough data to calculate Owner Earnings per Share (TTM). Please check Wal-Mart Stores Inc, as your reference.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


COSMOS Pharmaceutical Owner Earnings per Share (TTM) Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's Owner Earnings per Share (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


COSMOS Pharmaceutical (TSE:3349) Business Description

Traded in Other Exchanges
N/A
Address
4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (TSE:3349) Headlines

No Headlines